Commerzbank Aktiengesellschaft’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Commerzbank Aktiengesellschaft's PFE Position: Q1 2026 in Review
Commerzbank Aktiengesellschaft reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $2.14M and leaving 444,413 shares worth $12.5M. The position accounts for 0.26% of the portfolio, ranked #51.
Commerzbank Aktiengesellschaft first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $519M in Q2 2013. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Commerzbank Aktiengesellschaft held 444,413 shares of Pfizer worth $12.5M as of Q1 2026.
- Commerzbank Aktiengesellschaft sold 80,413 Pfizer shares in Q1 2026, an estimated $2.14M.
- Pfizer made up 0.26% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #51 holding.
- Commerzbank Aktiengesellschaft first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Commerzbank Aktiengesellschaft's Pfizer position peaked at $519M in Q2 2013.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.